FORCE’s eXamining the Relevance of Articles for Young Survivors (XRAYS) program is a reliable resource for breast cancer research-related news and information. XRAYS reviews new breast cancer research, provides plain-language summaries, and rates how the media covered the topic. XRAYS is funded by the CDC.
When a woman is newly diagnosed with a BRCA mutation, she faces many risk management decisions. Although many of these decisions impact family planning, little guidance is available on how to communicate this information. This study examines female previvors’ advice on effective strategies for discussing family planning decisions. (03/28/18)
U.S. News & World Report recently talked to three breast cancer survivors, including two young women, about how they handled out-of-pocket costs and other medical expenses after their cancer diagnosis. (Posted 1/4/18)
On December 7, 2017 the New England Journal of Medicine published results from a study by Lina Mørrch of the University of Copenhagen and colleagues showing that hormonal contraceptives (birth control) increase the risk of breast cancer. The study is unique because it is one of the first to specifically assess the breast cancer risk associated with newer, low-dosage methods of contraception. The large and significant effort analyzed medical data of nearly 1.8 million young women in Denmark on average for over 10.9 years. Results were covered widely in the U.S. by many major media outlets, including the New York Times, USA Today, Forbes and Time. (12/14/17)
Andrew Joseph’s piece for STAT, “A baby with a disease gene or no baby at all: Genetic testing of embryos creates an ethical morass,” focuses on preimplantation genetic diagnosis (PGD) and the emerging ethical issue in the field of reproductive medicine: What to do when patients seeking to get pregnant select embryos with DNA that could lead to a disease or a disability. (11/8/17)
The number of women who become pregnant around the time of, or after a breast cancer diagnosis is increasing. However, it is unclear whether pregnancy around the time of a breast cancer diagnosis impacts survival. This recently published study demonstrates that the timing of pregnancy does not negatively affect breast cancer survival rates. (5/24/17)
In vitro fertilization (IVF) wasn't commonly used until the 1980s, so its long-term effects are mostly unknown. A new study suggests that the treatment does not increase a woman's risk for developing breast cancer. (8/23/16)
Age affects fertility. As women age, their ovaries release eggs that are not as healthy as those released in younger women, and in general, fewer eggs each menstrual cycle, making it harder for older women to become pregnant. Are BRCA mutation carriers less fertile? Previous research suggested that BRCA mutations might affect women's fertility. A recent study found that BRCA1 mutation carriers may have slightly lower fertility than women without the same mutation, but more research is needed before this finding is useful for medical decision-making. (5/24/16)
Very little work has studied how a woman's cancer diagnosis and treatment during pregnancy affects her child. This study of women who were diagnosed with cancer while pregnant looks at their children at ages 18 months and 3 years. The study found no difference in general, cognitive, and cardiac development when compared to children born to healthy mothers.
Previous studies have shown that women who breastfeed have a reduced breast cancer risk. This study examines this association in the different breast cancer subtypes (ER, PR, HER2 negative/positive) and finds that breastfeeding is associated with a reduced risk of ER-/PR- breast cancer.
This study found an association between prenatal exposure to the pesticide DDT, and an increased risk of women developing breast cancer. While this study does not prove that DDT exposure directly causes breast cancer, it serves as a reminder that pregnant women's exposure to toxic environmental agents can affect their children's risk for disease later in life.